Kuros Biosciences’ Post

Right now, 60,000 ventriculostomies are performed each year in the US using archaic hand drill devices and ~20% result in brain damage or death. This incredible case study explains PA's collaboration with Hubly Surgical to reimagine a safer cranial drill. Our involvement with surgical projects like this, alongside our capability in more traditional drug delivery, gives us the essential mix of skills and experience to support pharma and biotech companies that need to target delivery of their medicines to challenging areas of the body.

Imalytics Preclinical can be used to segment various organs, structures, and regions of interest. In particular, bone structures are easily to distinguish in a CT data set due to their high Hounsfield units. This is useful to apply threshold functions for reliable and user-independent segmentation workflows. We have implemented a simple and fast workflow to segment a mouse knee. The following bones are segmented: tibia, femur, patella, fibula, lateral fabella, medial fabella, lateral ossified meniscus, and medial ossified meniscus. For more information, see the video: https://lnkd.in/dwFmwSfD --------------------- #gremseit #imalytics #preclinical #imaging #invivo #CT #bone #boneanalysis #imageanalysis #knee

✨ Excited to share a new technique at the upcoming VeithSymposium in New York (November 18-22) ✨ I’m honored to have been accepted as Associate Faculty to present my innovative surgical technique: “Misalignment In FEVAR: Technique To Ensure Cannulation Of Target Arteries In PMEG: In Vitro Testing And Proposal For An Off-The-Shelf Device.” This technique, which I developed and am working to refine, is designed to optimize target artery cannulation in PMEG procedures. Initial in vitro testing has shown promising results, and my goal is for this approach not only to enhance FEVAR procedures but to inspire the creation of a readily available device that can support surgeons in the field. I hope this innovation will spark interest within the vascular community, and perhaps even attract potential collaborators for the journey toward final design. To my colleagues and vascular health professionals, I look forward to connecting and exchanging ideas at VeithSymposium! #VeithSymposium #PMEG #VascularSurgery #FEVAR #MedicalInnovation #SurgicalInnovation #Endovascular #MedTech #HealthcareInnovation #MedicalDevice #InVitroTesting #VascularCommunity

♤ 𝐌𝐞𝐭𝐚-𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 ♤ Our meta-analysis title " 𝘌𝘧𝘧𝘪𝘤𝘢𝘤𝘺 𝘢𝘯𝘥 𝘚𝘢𝘧𝘦𝘵𝘺 𝘰𝘧 𝘓𝘪𝘨𝘢𝘚𝘶𝘳𝘦 𝘪𝘯 𝘉𝘳𝘦𝘢𝘴𝘵 𝘚𝘶𝘳𝘨𝘦𝘳𝘺 𝘸𝘪𝘵𝘩 𝘈𝘹𝘪𝘭𝘭𝘢𝘳𝘺 𝘓𝘺𝘮𝘱𝘩 𝘕𝘰𝘥𝘦 𝘋𝘪𝘴𝘴𝘦𝘤𝘵𝘪𝘰𝘯 𝘪𝘯 𝘗𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘸𝘪𝘵𝘩 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳: 𝘈 𝘚𝘺𝘴𝘵𝘦𝘮𝘢𝘵𝘪𝘤 𝘙𝘦𝘷𝘪𝘦𝘸 𝘢𝘯𝘥 𝘔𝘦𝘵𝘢-𝘈𝘯𝘢𝘭𝘺𝘴𝘪𝘴" is published in 𝐉𝐨𝐮𝐫𝐧𝐚𝐥 𝐨𝐟 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. ♤ LigaSure was associated with significantly lower post-operative drain volume (SMD: −0.39, 95% CI [-0.53, −0.24], P < 0.00001), shortened duration of drain (SMD: −0.51, 95% CI [-0.67, −0.34], P < 0.00001), and reduced hospital stay length (SMD: −0.57, 95% CI [-0.96, −0.18], P = 0.004) compared to conventional techniques. However, no difference observed in total operation time, intra-operative blood loss, seroma related outcomes and post-operative complications between the two groups. Great work by Muhammad Imran https://lnkd.in/eYdNMamc

🔹 Thulium Laser Enucleation + Morcellator Technique! 🔹 Just performed a Thulium Laser Enucleation for the removal of the prostate left and right lobes, followed by a precise morcellation technique. This is a 60cc prostate and patient failed medical therapy. 🚀 ⚙️ Procedure Highlights: ✨ Thulium Laser Enucleation for precise tissue removal ✨ Morcellation for efficient extraction of prostate lobes ✨ Minimally invasive approach for faster recovery #ProstateSurgery #ThuliumLaserEnucleation #Morcellator #InnovationInUrology #MinimallyInvasive #PatientOutcomes #MedicalBreakthrough #UrologyAdvancements #HealthcareInnovation #SurgicalInnovation #PrecisionSurgery

News: Avation Medical announces Jason Whiting has been named as Chief Executive Officer, bringing 25 years of success in the MedTech industry. Please join us in welcoming Jason to the Avation team! 📅 For more details, read the full press release on our website: Avation.com #Vivally #innovation #neuromodulation #OAB #AvationMedical #NewCEO Jason Whiting

Researchers from the Department of Gastrointestinal Surgery at the Third Xiangya Hospital of Central South University recently published their study on Materials Today Bio, announced that the team developed a new technique openning up new possibilities for localized controlled release of small molecule peptide drugs and can facilitate the creation of more effective and efficient anti-adhesion materials. The research team developed an injectable hydrogel incorporating peptides, choosing two raw materials, carboxymethyl chitosan (CMCS) and poloxamer F127, as a matrix for the hydrogel, and glycolaldehyde as a crosslinking agent to improve the mechanical properties of the hydrogel, as well as the Endostain ( ES, an angiogenesis inhibitor ) was incorporated into the hydrogel matrix and was able to be released slowly. In order to investigate the compatibility and biodegradation of the  above hydrogels in vivo organisms, the research team did in vivo  experiments using Clinx IVScope 8500 Small Animal In Vivo Imaging System. Read the full article here:➡ https://lnkd.in/guiM_nzv   #invivoimagingsystem

A New #Embolic for #MSK Unveiled at #ET2024? 🕵️♂️ 1/ 🧵 @YujiOkuno_OC et al. published the abstract "The future of #MSK embolotherapies: imageable biodegradable microspheres" Here is what we know about these biodegradable microspheres so far: 2/ 🎯 Purpose: An international team is investigating a novel embolic material that is rapidly dissolving, radiopaque, and echogenic, intended for musculoskeletal use. 🌍 #HealthTech 3/ 🧪 Methodology: These microspheres, are made from networked inorganic polymers (75-150 micron) and are designed to be visible on angiograms/CT and undergo "rapid dissolution via hydration and hydrolysis". 📊🩺 #MedicalResearch 4/ Through superselective transcatheter embolization in testing models, researchers evaluated the microspheres' effectiveness, injectability, and imaging capabilities. 🧑🔬🚀 #ClinicalTrials 5/ 🌟 Impact: The visibility of these microspheres was confirmed by multiple physicians on angiograms AND ultrasound! 💡🔎 #FutureOfMedicine 6/ 🔄 Next Steps: Further clinical evaluations are planned to assess the viability of this technology. #MSKEmbo data continues to evolve and so does the debate on #temporary vs. #permanent #embolics for #MSK #embolotherapy! 7/ What are your thoughts? @marklittle_IR @TheRealDoctorOs @SandeepBaglaMD @AriIsaacsonMD @thegestgroup @cirsesociety #GAE #KneePain #Ortho Follow us to stay up-to-date with the latest in #VIR #iRads! Subscribe to our newsletter: https://lnkd.in/gRwAjsEf

This article introduces the Olympus EVIS X1 Endoscopy System and describes how clinicians may benefit from the availability of several easy-to-use technologies aimed to revolutionize how to detect, characterize, and treat GI disorders. https://lnkd.in/eXmWVj_S

Fact: "Biomechanics combined with mobility analytics can accelerate bone healing by 22%. A study with 800 patients found that personalized exercise regimes not only speed up recovery but also improve patient satisfaction by 30%." #OrthopedicRehab